Modelling the course of an HIV infection: Insights from ecology and evolution

Viruses

Volumn 4, Issue 10, 2012, Pages 1984-2013

  Alizon, Samuel ^a   Magnus, Carsten ^b  

^a University de Montpellier   (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

AIDS; Computational biology; Evolution; HIV; Infection course; Mathematics; Modelling; Virus; Within host dynamics

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; LYMPHOCYTE PROLIFERATION; MATHEMATICAL MODEL; MICROBIAL DIVERSITY; MOLECULAR ECOLOGY; MOLECULAR EVOLUTION; NONHUMAN; POPULATION DYNAMICS; REVIEW; VIRION; VIRUS IMMUNITY; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; BIOLOGICAL EVOLUTION; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; HIV; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, BIOLOGICAL; POPULATION DYNAMICS; TIME FACTORS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84868148515     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v4101984     Document Type: Review

References (120)

1. Anderson, R.M.; May, R.M. Population biology of infectious diseases. Nature 1979, 280, 361-367.
2. Hofbauer, J.; Sigmund, K. Adaptive dynamics and evolutionary stability. Appl. Math. Lett. 1990, 3, 75-79.
3. Levy, J.A. Mysteries of HIV: Challenges for therapy and prevention. Nature 1988, 333, 519-522.
4. Pantaleo, G.; Graziosi, C.; Fauci, A.S. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 1993, 328, 327-335.
5. Clark, S.J.; Saag, M.S.; Decker, W.D.; Campbell-Hill, S.; Roberson, J.L.; Veldkamp, P.J.; Kappes, J.C.; Hahn, B.H.; Shaw, G.M. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 1991, 324, 954-960.
6. Daar, E.; Moudgil, T.; Meyer, R.; Ho, D. Transient high-levels of viremia in patients with primary human-immunodeficiency-virus type-1 infection. N. Engl. J. Med. 1991, 324, 961-964.
7. Tindall, B.; Cooper, D.A. Primary HIV infection: Host responses and intervention strategies. AIDS 1991, 5, 1-14.
8. Richman, D.D.; Wrin, T.; Little, S.J.; Petropoulos, C.J. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 2003, 100, 4144-4149.
9. Ho, D.; Neumann, A.; Perelson, A.; Chen, W.; Leonard, J.; Markowitz, M. Rapid turnover of plasma virions and CD4 Lymphocytes in HIV-1 infection. Nature 1995, 373, 123-126.
10. Shankarappa, R.; Margolick, J.B.; Gange, S.J.; Rodrigo, A.G.; Upchurch, D.; Farzadegan, H.; Gupta, P.; Rinaldo, C.R.; Learn, G.H.; He, X.; et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 1999, 73, 10489-10502.
11. Ho, D.D.; Mougdil, T.; Alam, M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 1989, 321, 1621-1625.
12. Coombs, R.W.; Collier, A.C.; Allain, J.P.; Nikora, B.; Leuther, M.; Gjerset, G.F.; Corey, L. Plasma viremia in human immunodeficiency virus infection. N. Engl. J. Med. 1989, 321, 1626-1631.
13. O'Brien, T.R.; Rosenberg, P.S.; Yellin, F.; Goedert, J.J. Longitudinal HIV-1 RNA levels in a cohort of homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 18, 155-161.
14. Lyles, C.M.; Dorrucci, M.; Vlahov, D.; Pezzotti, P.; Angarano, G.; Sinicco, A.; Alberici, F.; Alcorn, T.M.; Vella, S.; Rezza, G. Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: Correlates and temporal trends of virus load. J. Infect. Dis. 1999, 180, 1018-1024.
15. Moore, J.P.; Kitchen, S.G.; Pugach, P.; Zack, J.A. The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of Human Immunodeficiency Virus type 1 infection. AIDS Res. Hum. Retroviruses 2004, 20, 111-26.
16. Regoes, R.R.; Bonhoeffer, S. The HIV coreceptor switch: A population dynamical perspective. Trends Microbiol. 2005, 13, 269-277.
17. Shriner, D.; Liu, Y.; Nickle, D.C.; Mullins, J.I. Evolution of intrahost HIV-1 genetic diversity during chronic infection. Evolution 2006, 60, 1165-1176.
18. Tebit, D.M.; Nankya, I.; Arts, E.J.; Gao, Y. HIV diversity, recombination and disease progression: How does fitness "fit" into the puzzle? AIDS Rev. 2007, 9, 75-87.
19. Tajima, F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989, 123, 585-595.
20. Weiss, R.A. How does HIV cause AIDS? Science 1993, 260, 1273-1279.
21. De Boer, R.J.; Perelson, A.S. Target cell limited and immune control models of HIV infection: A comparison. J. Theor. Biol. 1998, 190, 201-214.
22. Bolker, B.M. Ecological Models and Data in R; Princeton University Press: Princeton, NJ, USA, 2008.
23. Yates, A.; Stark, J.; Klein, N.; Antia, R.; Callard, R. Understanding the slow depletion of memory CD4+ T cells in HIV infection. PLoS Med. 2007, 4, e177.
24. Perelson, A.S.; Nelson, P.W. Mathematical analysis of HIV-I dynamics in vivo. SIAM Rev. 1999, 41, 3-44.
25. Nowak, M.A.; May, R.M. Virus Dynamics: Mathematical Principles of Immunology and Virology; Oxford University Press: Oxford, UK, 2000.
26. Rambaut, A.; Posada, D.; Crandall, K.A.; Holmes, E.C. The causes and consequences of HIV evolution. Nat. Rev. Genet. 2004, 5, 52-61.
27. Perelson, A.S. Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2002, 2, 28-36.
28. Wei, X.; Ghosh, S.; Taylor, M.; Johnson, V.; Emini, E.; Deutsch, P.; Lifson, J.; Bonhoeffer, S.; Nowak, M.; Hahn, B.; Saag, M.; Shaw, G. Viral dynamics in human-immunodeficiency-virus type-1 infection. Nature 1995, 373, 117-122.
29. Perelson, A.S.; Neumann, A.U.; Markowitz, M.; Leonard, J.M.; Ho, D.D. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271, 1582-1586.
30. Bonhoeffer, S.; Lipsitch, M.; Levin, B.R. Evaluating treatment protocols to prevent antibiotic resistance. Proc. Natl. Acad. Sci. USA 1997, 94, 12106-12111.
31. Kirschner, D.; Webb, G.F.; Cloyd, M. Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4+ lymphocytes. J. Acquir. Immune. Defic. Syndr. 2000, 24, 352-362.
32. Janeway, C.; Travers, P.; Walport, M.; Shlomchik, M. Immunobiology, 6th ed.; Garland Science: Oxford, UK, 2004.
33. Stafford, M.A.; Corey, L.; Cao, Y.; Daar, E.S.; Ho, D.D.; Perelson, A.S. Modeling plasma virus concentration during primary HIV infection. J. Theor. Biol. 2000, 203, 285-301.
34. Nowak, M.A.; May, R.M.; Anderson, R.M. The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. AIDS 1990, 4, 1095-1103.
35. De Boer, R.J.; Ribeiro, R.M.; Perelson, A.S. Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues. PLoS Comput. Biol. 2010, 6, e1000906.
36. Perelson, A.S.; Kirschner, D.E.; de Boer, R. Dynamics of HIV infection of CD4+ T cells. Math. Biosci. 1993, 114, 81-125.
37. Essunger, P.; Perelson, A.S. Modeling HIV infection of CD4+ T-Cell subpopulations. J. Theor. Biol. 1994, 170, 367-391.
38. Kirschner, D. Using mathematics to understand HIV immune dynamics. AMS Notices 1996, 43, 191-202.
39. Kirschner, D.; Webb, G. A model for treatment strategy in the chemotherapy of AIDS. Bull. Math. Biol. 1996, 58, 367-390.
40. Fraser, C.; Ferguson, N.M.; Wolf, F.d.; Anderson, R.M. The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: Mechanisms and clinical implications. Proc. R. Soc. Lond. B 2001, 268, 2085-2095.
41. Ribeiro, R.M.; Hazenberg, M.D.; Perelson, A.S.; Davenport, M.P. Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in Human Immunodeficiency Virus type 1: Implications for therapy. J. Virol. 2006, 80, 802-809.
42. Bukrinsky, M.; Stanwick, T.; Dempsey, M.; Stevenson, M. Quiescent T Lymphocytes as an Inducible Virus Reservoir in HIV-1 Infection. Science 1991, 254, 423-427.
43. Phillips, R.E.; Rowland-Jones, S.; Nixon, D.F.; Gotch, F.M.; Edwards, J.P.; Ogunlesi, A.O.; Elvin, J.G.; Rothbard, J.A.; Bangham, C.R.; Rizza, C.R. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991, 354, 453-459.
44. Troyer, R.M.; Collins, K.R.; Abraha, A.; Fraundorf, E.; Moore, D.M.; Krizan, R.W.; Toossi, Z.; Colebunders, R.L.; Jensen, M.A.; Mullins, J.I.; et al. Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J. Virol. 2005, 79, 9006-9018.
45. Kouyos, R.D.; von Wyl, V.; Hinkley, T.; Petropoulos, C.J.; Haddad, M.; Whitcomb, J.M.; Böni, J.; Yerly, S.; Cellerai, C.; Klimkait, T.; Günthard, H.F.; Bonhoeffer, S. Swiss HIV Cohort Study. Assessing predicted HIV-1 replicative capacity in a clinical setting. PLoS Pathog. 2011, 7, e1002321.
46. Stilianakis, N.I.N.; Schenzle, D.D.; Dietz, K.K. On the antigenic diversity threshold model for AIDS. Math. Biosci. 1994, 121, 235-247.
47. Nowak, M.A.; May, R.M. Mathematical biology of HIV infections: Antigenic variation and diversity threshold. Math. Biosci. 1991, 106, 1-21.
48. Regoes, R.R.; Wodarz, D.; Nowak, M.A. Virus dynamics: The effect of target cell limitation and immune responses on virus evolution. J. Theor. Biol. 1998, 191, 451-462.
49. Iwami, S.; Nakaoka, S.; Takeuchi, Y. Viral diversity limits immune diversity in asymptomatic phase of HIV infection. Theor. Popul. Biol. 2008, 73, 332-341.
50. Nowak, M.A.; Anderson, R.M.; McLean, A.R.; Wolfs, T.F.; Goudsmit, J.; May, R.M. Antigenic diversity thresholds and the development of AIDS. Science 1991, 254, 963-9.
51. Wolinsky, S.M.; Korber, B.T.; Neumann, A.U.; Daniels, M.; Kunstman, K.J.; Whetsell, A.J.; Furtado, M.R.; Cao, Y.; Ho, D.D.; Safrit, J.T. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996, 272, 537-542.
52. Nowak, M.A.; Anderson, R.M.; Boerlijst, M.C.; Bonhoeffer, S.; May, R.M.; McMichael, A.J. HIV-1 evolution and disease progression. Science 1996, 274, 1008-1011.
53. Alizon, S.; van Baalen, M. Multiple infections, immune dynamics and virulence evolution. Am. Nat. 2008, 172, E150-E158.
54. Schenzle, D. A model for AIDS pathogenesis. Stat. Med. 1994, 13, 2067-2079.
55. Iwasa, Y.; Michor, F.; Nowak, M.A. Virus evolution within patients increases pathogenicity. J. Theor. Biol. 2005, 232, 17-26.
56. Day, T.; Proulx, S.R. A general theory for the evolutionary dynamics of virulence. Am. Nat. 2004, 163, E40-E63.
57. Alizon, S. The Price equation framework to study disease within-host evolution. J. Evol. Biol. 2009, 22, 1123-1132.
58. Stilianakis, N.I.N.; Dietz, K.K.; Schenzle, D.D. Analysis of a model for the pathogenesis of AIDS. Math. Biosci. 1997, 145, 27-46.
59. Stilianakis, N.I.N.; Schenzle, D.D. On the intra-host dynamics of HIV-1 infections. Math. Biosci. 2006, 199, 1-25.
60. Ball, C.L.; Gilchrist, M.A.; Coombs, D. Modeling within-host evolution of HIV: Mutation, competition and strain replacement. Bull. Math. Biol. 2007, 69, 2361-2385.
61. Gilchrist, M.A.; Coombs, D.; Perelson, A.S. Optimizing within-host viral fitness: Infected cell lifespan and virion production rate. J. Theor. Biol. 2004, 229, 281-288.
62. Huang, G.; Takeuchi, Y.; Korobeinikov, A. HIV evolution and progression of the infection to AIDS. J. Theor. Biol. 2012, 307, 149-59.
63. Alizon, S.; Boldin, B. Within-host viral evolution in a heterogeneous environment. Insights into the HIV co-receptor switch. J. Evol. Biol. 2010, 23, 2625-2635.
64. Eigen, M.; McCaskill, J.; Schuster, P. Molecular Quasi-species. J. Phys. Chem. 1988, 92, 6881-6891.
65. Kamp, C. Understanding the HIV coreceptor switch from a dynamical perspective. BMC Evol. Biol. 2009, 9, doi:10.1186/1471-2148-9-274.
66. Sguanci, L.; Bagnoli, F.; Lio, P. Modeling HIV quasispecies evolutionary dynamics. BMC Evol. Biol. 2007, 7, doi:10.1186/1471-2148-7-S2-S5.
67. Boily, M.C.; Baggaley, R.F.; Wang, L.; Masse, B.; White, R.G.; Hayes, R.J.; Alary, M. Heterosexual risk of HIV-1 infection per sexual act: Systematic review and meta-analysis of observational studies. Lancet Infect. Dis. 2009, 9, 118-129.
68. Keele, B.F.; Giorgi, E.E.; Salazar-Gonzalez, J.F.; Decker, J.M.; Pham, K.T.; Salazar, M.G.; Sun, C.; Grayson, T.; Wang, S.; Li, H.; et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 2008, 105, 7552-7557.
69. Tan, W.Y.; Wu, H. Stochastic modeling of the dynamics of CD4+ T-cell infection by HIV and some Monte Carlo studies. Math. Biosci. 1998, 147, 173-205.
70. Kamina, A.; Makuch, R.W.; Zhao, H. A stochastic modeling of early HIV-1 population dynamics. Math. Biosci. 2001, 170, 187-198.
71. Heffernan, J.M.; Wahl, L.M. Monte Carlo estimates of natural variation in HIV infection. J. Theor. Biol. 2005, 236, 137-153.
72. Gillespie, D.T. Exact stochastic simulation of coupled chemical reactions. J. Phys. Chem. 1977, 81, 2340-2361.
73. Pearson, J.E.; Krapivsky, P.; Perelson, A.S. Stochastic theory of early viral infection: Continuous versus burst production of virions. PLoS Comput. Biol. 2011, 7, e1001058.
74. Tuckwell, H.C.; Le Corfec, E. A stochastic model for early HIV-1 population dynamics. J. Theor. Biol. 1998, 195, 451-463.
75. Merrill, S.J. The stochastic dance of early HIV infection. J. Comput. Appl. Math. 2005, 184, 242-257.
76. Lee, H.Y.; Giorgi, E.E.; Keele, B.F.; Gaschen, B.; Athreya, G.S.; Salazar-Gonzalez, J.F.; Pham, K.T.; Goepfert, P.A.; Kilby, J.M.; Saag, M.S.; et al. Modeling sequence evolution in acute HIV-1 infection. J. Theor. Biol. 2009, 261, 341-360.
77. Tuckwell, H.C.; Shipman, P.D.; Perelson, A.S. The probability of HIV infection in a new host and its reduction with microbicides. Math. Biosci. 2008, 214, 81-86.
78. Levin, B.R.; Bull, J.J. Short-sighted evolution and the virulence of pathogenic microorganisms. Trends Microbiol. 1994, 2, 76-81.
79. Zorzenon dos Santos, R.; Coutinho, S. Dynamics of HIV infection: A cellular automata approach. Phys. Rev. Lett. 2001, 87.
80. Strain, M.; Levine, H. Comment on "Dynamics of HIV Infection: A cellular automata approach". Phys. Rev. Lett. 2002, 89.
81. Strain, M.; Richman, D.; Wong, J.; Levine, H. Spatiotemporal dynamics of HIV propagation. J. Theor. Biol. 2002, 218, 85-96.
82. Bauer, A.L.; Beauchemin, C.A.A.; Perelson, A.S. Agent-based modeling of host-pathogen systems: The successes and challenges. Inf. Sci. 2009, 179, 1379-1389.
83. Lin, H.; Shuai, J.W. A stochastic spatial model of HIV dynamics with an asymmetric battle between the virus and the immune system. New J. Phys. 2010, 12, doi:10.1088/1367-2630/12/4/043051.
84. Lion, S.; van Baalen, M. Self-structuring in spatial evolutionary ecology. Ecol. Lett. 2008, 11, 277-295.
85. Bonhoeffer, S.; Nowak, M.A. Intra-host versus inter-host selection: Viral strategies of immune function impairment. Proc. Natl. Acad. Sci. USA 1994, 91, 8062-8066.
86. Lemey, P.; Rambaut, A.; Pybus, O.G. HIV evolutionary dynamics within and among hosts. AIDS Rev. 2006, 8, 125-140.
87. Pybus, O.G.; Rambaut, A. Evolutionary analysis of the dynamics of viral infectious disease. Nat. Rev. Genet. 2009, 10, 540-550.
88. Lythgoe, K.; Fraser, C. New insights into the evolutionary rate of HIV-1 at the within-host and epidemiological levels. Proc. R. Soc. Lond. B 2012, 279, 3367-3375.
89. Robertson, D.L.; Sharp, P.M.; McCutchan, F.E.; Hahn, B.H. Recombination in HIV-1. Nature 1995, 374, 124-126.
90. Jung, A.; Maier, R.; Vartanian, J.P.; Bocharov, G.; Jung, V.; Fischer, U.; Meese, E.; Wain-Hobson, S.; Meyerhans, A. Recombination: Multiply infected spleen cells in HIV patients. Nature 2002, 418, doi:10.1038/418144a.
91. Levy, D.N.; Aldrovandi, G.M.; Kutsch, O.; Shaw, G.M. Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. USA 2004, 101, 4204-4209.
92. Dixit, N.M.; Perelson, A.S. HIV dynamics with multiple infections of target cells. Proc. Natl. Acad. Sci. USA 2005, 102, 8198-8203.
93. Bretscher, M.T.; Althaus, C.L.; Müller, V.; Bonhoeffer, S. Recombination in HIV and the evolution of drug resistance: For better or for worse? Bioessays 2004, 26, 180-188.
94. Althaus, C.L.; Bonhoeffer, S. Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1. J. Virol. 2005, 79, 13572-13578.
95. Sigal, A.; Kim, J.T.; Balazs, A.B.; Dekel, E.; Mayo, A.; Milo, R.; Baltimore, D. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature 2011, 477, 95-98.
96. Bartha, I.; Simon, P.; Müller, V. Has HIV evolved to induce immune pathogenesis? Trends Immunol. 2008, 29, 322-328.
97. Graham, A.L.; Allen, J.E.; Read, A.F. Evolutionary causes and consequences of immunopathology. Annu. Rev. Ecol. Evol. Syst. 2005, 36, 373-397.
98. Lion, S.; Jansen, V.A.A.; Day, T. Evolution in structured populations: Beyond the kin versus group debate. Trends Ecol. Evol. 2011, 26, 193-201.
99. Hellerstein, M.; Hanley, M.B.; Cesar, D.; Siler, S.; Papageorgopoulos, C.; Wieder, E.; Schmidt, D.; Hoh, R.; Neese, R.; Macallan, D.; et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 1999, 5, 83-89.
100. Galvani, A. The role of mutation accumulation in HIV progression. Proc. R. Soc. Lond. B 2005, 272, 1851-1858.
101. Korthals Altes, H.; De Boer, R.; Boerlijst, M. Role of avidity and breadth of the CD4 T cell response in progression to AIDS. Proc. R. Soc. Lond. B 2006, 273, 1697-1704.
102. Hogue, I.B.; Bajaria, S.H.; Fallert, B.A.; Qin, S.; Reinhart, T.A.; Kirschner, D.E. The dual role of dendritic cells in the immune response to human immunodeficiency virus type 1 infection. J. Gen. Virol. 2008, 89, 2228-2239.
103. Steinman, R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991, 9, 271-296.
104. Lekkerkerker, A.N.; van Kooyk, Y.; Geijtenbeek, T.B.H. Viral piracy: HIV-1 targets dendritic cells for transmission. Curr. HIV Res. 2006, 4, 169-176.
105. Iwami, S.; Miura, T.; Nakaoka, S.; Takeuchi, Y. Immune impairment in HIV infection: Existence of risky and immunodeficiency thresholds. J. Theor. Biol. 2009, 260, 490-501.
106. Fawcett, T.W.; Higginson, A.D. Heavy use of equations impedes communication among biologists. Proc. Natl. Acad. Sci. USA 2012, doi:10.1073/pnas.1205259109.
107. Jeffrey, A.; Xia, X. Identifiability of HIV/AIDS Model. In Deterministic and Stochastic Models of AIDS Epidemics and HIV Infections with Intervention; Tan, W.Y., Wu, H., Eds.; World Scientific Publishing Co. Pte. Ltd.: Singapore, 2005.
108. Wu, H.; Zhu, H.; Miao, H.; Perelson, A.S. Parameter identifiability and estimation of HIV/AIDS dynamic models. Bull. Math. Biol. 2008, 70, 785-799.
109. Muller, V.; Marée, A.F.M.; De Boer, R.J. Small variations in multiple parameters account for wide variations in HIV-1 set-points: A novel modelling approach. Proc. R. Soc. Lond. B 2001, 268, 235-242.
110. Alter, M.J. Epidemiology of viral hepatitis and HIV co-infection. J. Hepatol. 2006, 44, S6-S9.
111. Pawlowski, A.; Jansson, M.; Sköld, M.; Rottenberg, M.E.; Källenius, G. Tuberculosis and HIV co-infection. PLoS Pathog. 2012, 8, e1002464.
112. McLean, A.R.; Kirkwood, T. A model of human immunodeficiency virus infection in T-Helper cell clones. J. Theor. Biol. 1990, 147, 177-203.
113. McLean, A.R.; Nowak, M.A. Models of interactions between HIV and other pathogens. J. Theor. Biol. 1992, 155, 69-86.
114. Zeng, M.; Southern, P.J.; Reilly, C.S.; Beilman, G.J.; Chipman, J.G.; Schacker, T.W.; Haase, A.T. Lymphoid tissue damage in HIV-1 infection depletes Naïve T cells and limits t cell reconstitution after antiretroviral therapy. PLoS Pathog. 2012, 8, e1002437.
115. Kepler, T.B.; Perelson, A.S. Drug concentration heterogeneity facilitates the evolution of drug resistance. Proc. Natl. Acad. Sci. USA 1998, 95, 11514-11519.
116. Frost, S.D.W.; Dumaurier, M.J.; Wain-Hobson, S.; Brown, A.J.L. Genetic drift and within-host metapopulation dynamics of HIV-1 infection. Proc. Natl. Acad. Sci. USA 2001, 98, 6975-6980.
117. Orive, M.E.; Stearns, M.N.; Kelly, J.K.; Barfield, M.; Smith, M.S.; Holt, R.D. Viral infection in internally structured hosts. I. Conditions for persistent infection. J. Theor. Biol. 2005, 232, 453-466.
118. Funk, G.A.; Jansen, V.A.A.; Bonhoeffer, S.; Killingback, T. Spatial models of virus-immune dynamics. J. Theor. Biol. 2005, 233, 221-236.
119. Douek, D.C.; Roederer, M.; Koup, R.A. Emerging Concepts in the Immunopathogenesis of AIDS. Ann. Rev. Med. 2009, 60, 471-484.
120. Sandler, N.G.; Douek, D.C. Microbial translocation in HIV infection: Causes, consequences and treatment opportunities. Nat. Rev. Microbiol. 2012, 10, 655-666.